| Reduced Risk Status: |
|
| IPM Compatibility: |
Per requestor: IPM comment unknown:06/23
|
| Reasons for need: |
Request for import:06/23
|
| Requesting State(s): |
NY:Goggi, P* ;
|
| PCR Use Pattern: |
|
| EPA Default Residue Trials: |
|
| IR-4 Residue Trial Plan: |
|
| Residue Protocol Use Pattern: |
|
| Efficacy/Crop Safety (E/CS) Data Required: |
|
| E/CS Research Comments: |
|
| Label Use Pattern Submitted To EPA: |
|
| EPA PIF Status: |
Orange 08/23, 8/24
|
| EPA Status: |
|
| EPA PRIA Date: |
|
| MRID: |
|
| Comments: |
EPA HOLD CAUTION:08/23, 8/24; this is included in the proposed l-glufosinate label:06/24/sb
|
| International Status: |
|
| Archive Location: |
|
| QA Archive: |
|